Precision Business Insights has published a report on the global oral solid dosage contract manufacturing market, estimating its value at USD 38.7 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/oral-solid-dosage-contract-manufacturing-market

Market Definition:

Because of their ease of use, precise dosing, stability, manufacturing efficiency, and broad acceptance, oral solid dosage forms such as tablets and capsules are the preferred option for drug formulation. This makes them perfect for delivering medications when these factors are important.

Drivers:

1)      Increasing demand for generic drugs

2)      Rising adoption of CDMOs for outsourcing manufacturing

The global Oral solid dosage contract manufacturing market segmentation:
1) By Product Type: Tablets, Capsules, Powders & Granules (MT).
2) By Release Mechanism: Tablets (Immediate Release, Modified Release, Chewable Tablets, Effervescent Tablets.
3) By Capsules: Controlled Release, Enteric Release, Others), Powders & Granules (Uncoated Powders & Granules, Coated Granules
4) By End User: Big Pharma or Biotech, Small & Medium Size Pharma or Biotech, Emerging or Virtual Pharma, Nutraceutical Companies

Regional Overview:
The report also examines the current concerns and their Future Effects on the oral solid dosage contract manufacturing market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the oral solid dosage contract manufacturing market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The key players profiled in the global oral solid dosage contract manufacturing market report are Abbvie Inc., Alcami Corporation, Cambrex Corporation (Halo Pharma), CMIC HOLDINGS Co., LTD., Confab Laboratories Inc., CordenPharma International, GENVION Corporation, Lonza Group AG, Mayne Pharma (Metrics Contract Services), Pfizer Inc., Pharma Tech Industries, Piramal Enterprises Ltd., PNP Pharmaceuticals Inc., ThermoFisher Scientific Inc. (Patheon N.V.), Tower Laboratories Ltd.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747